Pure μ-opioids (methadone, morphine, hydromorphone) provide profound analgesia and are preferred for extensive dental procedures. Partial agonists (buprenorphine) are suitable for moderate pain.
Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today provides a business update highlighting the ...
SafeHeal(R) , a leading innovator in the field of colorectal cancer surgery, today announced the first patient enrollment in its pivotal IDE study of Colovac(R), a groundbreaking endoluminal bypass ...
Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...
Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how ...
Medications have become our go-to treatments for opioid addiction. Though life-saving, their downsides are underappreciated ...
According to new research, radiation therapy administered before surgery rarely produces favorable responses in patients with ...
New options for testing and treating some of the most common sexually transmitted diseases are becoming available ...
Over 40% of people taking Xenical achieved a 5% decrease in their starting body weight. Saxenda users achieved a 5% decrease in their body weight in more than 63% of cases. Eating a balanced diet and ...
In an advance that could help ensure people are taking their medication on schedule, MIT engineers have designed a pill that ...
Everyday Health on MSN
There’s a New Drug for Motion Sickness — the First in 40 Years
The FDA approved the pill Nereus (tradipitant) as a new treatment for vomiting caused by motion sickness, with fewer side ...
Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive. In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results